ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVIR Atea Pharmaceuticals Inc

4.035
0.035 (0.88%)
Last Updated: 00:48:03
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Atea Pharmaceuticals Inc AVIR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.035 0.88% 4.035 00:48:03
Open Price Low Price High Price Close Price Previous Close
3.98 3.98 4.035 4.00
more quote information »

Recent News

Date Time Source Heading
27/3/202422:00GLOBEAtea Pharmaceuticals Completes Patient Enrollment in Global..
29/2/202408:18EDGAR2Form 8-K - Current report
29/2/202408:05GLOBEAtea Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202423:00GLOBEAtea Pharmaceuticals to Host Fourth Quarter and Full Year..
03/2/202413:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202413:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202413:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202413:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202408:15EDGAR2Form 144 - Report of proposed sale of securities
02/2/202408:15EDGAR2Form 144 - Report of proposed sale of securities
02/2/202408:15EDGAR2Form 144 - Report of proposed sale of securities
09/1/202408:05GLOBEAtea Pharmaceuticals Announces Positive Initial Data from..
03/1/202423:00GLOBEAtea Pharmaceuticals to Present at the 42nd Annual J.P...
13/11/202323:00GLOBEAtea Pharmaceuticals Presents Promising Bemnifosbuvir and..
09/11/202308:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:15EDGAR2Form 8-K - Current report
09/11/202308:05GLOBEAtea Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202323:00GLOBEAtea Pharmaceuticals Announces Participation at Upcoming..
02/11/202322:00GLOBEAtea Pharmaceuticals to Present Bemnifosbuvir and Ruzasvir..
01/11/202322:00GLOBEAtea Pharmaceuticals to Host Third Quarter 2023 Financial..
06/9/202321:00GLOBEAtea Pharmaceuticals to Present at the Morgan Stanley 21st..
09/8/202306:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:21EDGAR2Form 8-K - Current report
09/8/202306:05GLOBEAtea Pharmaceuticals Reports Second Quarter 2023 Financial..
01/8/202321:00GLOBEAtea Pharmaceuticals to Host Second Quarter 2023 Financial..
15/6/202321:00GLOBEAtea Pharmaceuticals Announces First Patient Dosed in Phase..
06/6/202306:20GLOBEAtea Pharmaceuticals to Present at the Jefferies Healthcare..
30/5/202321:00GLOBEAtea Pharmaceuticals’ Board of Directors Unanimously Rejects..
24/5/202306:05GLOBEAtea Pharmaceuticals Confirms Receipt of Unsolicited..
09/5/202306:05GLOBEAtea Pharmaceuticals Reports First Quarter 2023 Financial..
02/5/202306:05GLOBEAtea Pharmaceuticals to Host First Quarter 2023 Financial..
25/4/202321:00GLOBEAtea Pharmaceuticals Announces U.S. FDA Fast Track..
12/4/202321:00GLOBEAtea Announces Presentation of Bemnifosbuvir Data..

Your Recent History

Delayed Upgrade Clock